Literature DB >> 19329268

Maturation of inhibitory and excitatory motor cortex pathways in children.

Michael Walther1, Steffen Berweck, Joachim Schessl, Michaela Linder-Lucht, Urban M Fietzek, Franz X Glocker, Florian Heinen, Volker Mall.   

Abstract

OBJECTIVE: To study intracortical inhibition and facilitation with paired-pulse transcranial magnetic stimulation in children, adolescents and adults.
METHODS: Paired-pulse transcranial magnetic stimulation (interstimulus intervals (ISI): 1, 3, 5, 10 and 20 ms) was applied over the primary motor cortex (M1) in 30 healthy subjects (range 6-30 years, median age 15 years and 8 months, SD 7,9) divided in three groups: adults (>or=18 years), adolescents (> 10 and < 18 years) and children (<or=10 years).
RESULTS: We observed significantly less intracortical inhibition (SICI) in children's M1 compared to that of adults. Adolescents showed significantly less SICI at the 5 ms interval than did adults. No significant differences were apparent in intracortical facilitation (ICF).
CONCLUSION: We postulate that, as in adults, the maturing M1 possesses horizontal glutamatergic cross-links that represent the neuronal substrate of excitatory intracortical pathways. GABAergic interneurons, the neuronal substrate of inhibitory intracortical pathways, mature between childhood and adulthood. Reduced GABAergic inhibition may facilitate neuronal plasticity and motor learning in children.

Entities:  

Mesh:

Year:  2009        PMID: 19329268     DOI: 10.1016/j.braindev.2009.02.007

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  9 in total

1.  GABAergic signaling increases through the postnatal development to provide the potent inhibitory capability for the maturing demands of the prefrontal cortex.

Authors:  Jihong Cui; Fang Wang; Ke Wang; Hui Xiang
Journal:  Cell Mol Neurobiol       Date:  2009-11-17       Impact factor: 5.046

2.  Development of cortical motor circuits between childhood and adulthood: A navigated TMS-HdEEG study.

Authors:  Sara Määttä; Mervi Könönen; Elisa Kallioniemi; Timo Lakka; Niina Lintu; Virpi Lindi; Florinda Ferreri; David Ponzo; Laura Säisänen
Journal:  Hum Brain Mapp       Date:  2017-02-20       Impact factor: 5.038

3.  Intracortical Inhibition Within the Primary Motor Cortex Can Be Modulated by Changing the Focus of Attention.

Authors:  Yves-Alain Kuhn; Martin Keller; Jan Ruffieux; Wolfgang Taube
Journal:  J Vis Exp       Date:  2017-09-11       Impact factor: 1.355

Review 4.  Noninvasive Brain Stimulation in Pediatric Attention-Deficit Hyperactivity Disorder (ADHD): A Review.

Authors:  Belen Rubio; Aaron D Boes; Simon Laganiere; Alexander Rotenberg; Danique Jeurissen; Alvaro Pascual-Leone
Journal:  J Child Neurol       Date:  2015-12-10       Impact factor: 1.987

5.  Biomarkers Obtained by Transcranial Magnetic Stimulation in Neurodevelopmental Disorders.

Authors:  Ali Jannati; Mary A Ryan; Harper L Kaye; Melissa Tsuboyama; Alexander Rotenberg
Journal:  J Clin Neurophysiol       Date:  2022-02-01       Impact factor: 2.177

Review 6.  Changes in Standing and Walking Performance Under Dual-Task Conditions Across the Lifespan.

Authors:  Jan Ruffieux; Martin Keller; Benedikt Lauber; Wolfgang Taube
Journal:  Sports Med       Date:  2015-12       Impact factor: 11.136

7.  Modulation of corticospinal excitability by transcranial magnetic stimulation in children and adolescents with autism spectrum disorder.

Authors:  Lindsay M Oberman; Alvaro Pascual-Leone; Alexander Rotenberg
Journal:  Front Hum Neurosci       Date:  2014-08-13       Impact factor: 3.169

8.  Adopting an external focus of attention alters intracortical inhibition within the primary motor cortex.

Authors:  Y-A Kuhn; M Keller; J Ruffieux; W Taube
Journal:  Acta Physiol (Oxf)       Date:  2016-10-17       Impact factor: 6.311

Review 9.  Sensorimotor Integration in Childhood Dystonia and Dystonic Cerebral Palsy-A Developmental Perspective.

Authors:  Verity M McClelland; Jean-Pierre Lin
Journal:  Front Neurol       Date:  2021-07-23       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.